References
- Ichikawa H, Shimizu K, Hayashi Y, Ohki M. An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation. Cancer Res 1994; 54: 2865–2768
- Kong X T, Ida K, Ichikawa H, Shimizu K, Ohki M, Maseki N, et al. Consistent detection of TLS/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(p11;q22) and identification of a novel transcript. Blood 1997; 90: 1192–1199
- Shing D C, McMullan D J, Roberts P, Smith K, Chin S F, Nicholson J, et al. FUS/ERG gene fusions in Ewing's tumors. Cancer Res 2003; 63: 4568–4576
- Okoshi Y, Shimizu S, Kojima H, Obara N, Mukai H Y, Komeno T, et al. Detection of minimal residual disease in a patient having acute myelogenous leukemia with t(16;21)(p11;q22) treated by allogeneic bone marrow transplantation. Acta Haematol 2001; 105: 45–48
- Shimizu K, Ichikawa H, Tojo A, Kaneko Y, Maseki N, Hayashi Y, et al. An ets-related gene, ERG, is rearranged in human myeloid leukemia with t(16;21) chromosomal translocation. Proc Natl Acad Sci USA 1993; 90: 10280–10284
- Panagopoulos I, Aman P, Fioretos T, Hoglund M, Johansson B, Mandahl N, et al. Fusion of the FUS gene with ERG in acute myeloid leukemia with t(16;21)(p11;q22). Genes Chromosomes Cancer 1994; 11: 256–262
- Pereira D S, Dorrell C, Ito C Y, Gan O I, Murdoch B, Rao V N, et al. Retroviral transduction of TLS-ERG initiates a leukemogenic program in normal human hematopoietic cells. Oncogene 1997; 15: 1357–1362
- Hicks G G, Singh N, Nashabi A, Mai S, Bozek G, Klewes L, et al. Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death. Nat Genet 2000; 24: 175–179